Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| A3191127 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To study Celebrex versus naproxen to see if it decreases symptoms of juvenile arthritis such as pain and swelling.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| High Dose | Experimental |
| |
| Low Dose | Experimental |
| |
| Naproxen | Active Comparator | Control comparator, 15 mg/kg/dy target dose |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Celecoxib | Drug | Higher dose, 6 mg/kg/dose BID |
| |
| Celecoxib |
| Measure | Description | Time Frame |
|---|---|---|
| ACR Pediatric 30 | 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Peds QOL | 12 weeks | |
| composites of acr 30 | 12 weeks |
Not provided
Inclusion Criteria:
2-18 years old with active JRA
Exclusion Criteria:
other experimental meds, recent changes in arthritis meds
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | San Diego | California | 92123 | United States | ||
| Pfizer Investigational Site |
Not provided
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
Active drug at lower dose |
|
| Naproxen | Drug | Control comparator, 15 mg/kg/dy target dose |
|
| Hartford |
| Connecticut |
| 06106 |
| United States |
| Pfizer Investigational Site | Delray Beach | Florida | 33484 | United States |
| Pfizer Investigational Site | Miami | Florida | 33155 | United States |
| Pfizer Investigational Site | St. Petersburg | Florida | 33701 | United States |
| Pfizer Investigational Site | Chicago | Illinois | 60614 | United States |
| Pfizer Investigational Site | Chicago | Illinois | 60637 | United States |
| Pfizer Investigational Site | Chicago | Illinois | 60649 | United States |
| Pfizer Investigational Site | Glenview | Illinois | 60025 | United States |
| Pfizer Investigational Site | Hinsdale | Illinois | 60521 | United States |
| Pfizer Investigational Site | Merrillville | Indiana | 46410 | United States |
| Pfizer Investigational Site | New Orleans | Louisiana | 70118 | United States |
| Pfizer Investigational Site | Boston | Massachusetts | 02115 | United States |
| Pfizer Investigational Site | Worcester | Massachusetts | 01610 | United States |
| Pfizer Investigational Site | Omaha | Nebraska | 68178 | United States |
| Pfizer Investigational Site | Livingston | New Jersey | 07039 | United States |
| Pfizer Investigational Site | New Hyde Park | New York | 11040 | United States |
| Pfizer Investigational Site | New York | New York | 10032 | United States |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74133 | United States |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74135 | United States |
| Pfizer Investigational Site | Portland | Oregon | 97210 | United States |
| Pfizer Investigational Site | Portland | Oregon | 97227-1623 | United States |
| Pfizer Investigational Site | Portland | Oregon | 97232 | United States |
| Pfizer Investigational Site | Altoona | Pennsylvania | 16601 | United States |
| Pfizer Investigational Site | Altoona | Pennsylvania | 16602 | United States |
| Pfizer Investigational Site | Duncansville | Pennsylvania | 16635 | United States |
| Pfizer Investigational Site | Hershey | Pennsylvania | 17033 | United States |
| Pfizer Investigational Site | Johnstown | Pennsylvania | 15904 | United States |
| Pfizer Investigational Site | Lancaster | Pennsylvania | 17604 | United States |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53201 | United States |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53226-0509 | United States |
| Pfizer Investigational Site | Leuven | 3000 | Belgium |
| Pfizer Investigational Site | Rio de Janeiro | Rio de Janeiro | 20551-030 | Brazil |
| Pfizer Investigational Site | Rio de Janeiro | Rio de Janeiro | 21944-970 | Brazil |
| Pfizer Investigational Site | São Paulo | São Paulo | 04025-002 | Brazil |
| Pfizer Investigational Site | São Paulo | São Paulo | 05403-901 | Brazil |
| Pfizer Investigational Site | Saskatoon | Saskatchewan | Canada |
| Pfizer Investigational Site | Århus N | 8200 | Denmark |
| Pfizer Investigational Site | Vandœuvre-lès-Nancy | 54511 | France |
| Pfizer Investigational Site | Berlin | 13125 | Germany |
| Pfizer Investigational Site | Bremen | 28205 | Germany |
| Pfizer Investigational Site | Halle | 06120 | Germany |
| Pfizer Investigational Site | Hamburg | 22081 | Germany |
| Pfizer Investigational Site | Hanover | 30625 | Germany |
| Pfizer Investigational Site | Monterrey | Nuevo León | 64460 | Mexico |
| Pfizer Investigational Site | Guadalajara | 44650 | Mexico |
| Pfizer Investigational Site | Lima | Lima Province | L05 | Peru |
| Pfizer Investigational Site | Lima | Lima Province | L13 | Peru |
| Pfizer Investigational Site | Lima | Lima Province | L31 | Peru |
| Pfizer Investigational Site | Vila Nova de Famalicão | 4764-901 | Portugal |
| Pfizer Investigational Site | Moscow | 115522 | Russia |
| Pfizer Investigational Site | Moscow | 119296 | Russia |
| Pfizer Investigational Site | Piešťany | 921 01 | Slovakia |
| Pfizer Investigational Site | Ljubljana | 1525 | Slovenia |
| Pfizer Investigational Site | Madrid | Madrid | 28009 | Spain |
| Pfizer Investigational Site | Madrid | Madrid | 28034 | Spain |
| Pfizer Investigational Site | Valencia | Valencia | 46009 | Spain |
| Pfizer Investigational Site | Stockholm | SE-17176 | Sweden |
| ID | Term |
|---|---|
| D001171 | Arthritis, Juvenile |
| D001168 | Arthritis |
| ID | Term |
|---|---|
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000068579 | Celecoxib |
| D009288 | Naproxen |
| ID | Term |
|---|---|
| D000096926 | Benzenesulfonamides |
| D013449 | Sulfonamides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D013450 | Sulfones |
| D013457 | Sulfur Compounds |
| D011720 | Pyrazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D009280 | Naphthaleneacetic Acids |
| D009281 | Naphthalenes |
| D011084 | Polycyclic Aromatic Hydrocarbons |
| D011083 | Polycyclic Compounds |
Not provided
Not provided